ALLOS THERAPEUTICS INC Active Patents
3 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2014-08-25: Application 14467812; Invention (2S)-2-[[4-[(1R)-1-[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]BUT-3-YNYL]BENZOYL]AMINO]PENTANEDIOIC ACID FOR THE TREATMENT OF INFLAMMATORY DISORDERS; Applicant Allos Therapeutics, Inc.; Status Patented Case.
- 2013-07-17: Application 13944596; Invention Combination of 10-Propargyl-10-Deazaaminopterin and Erlotinib for the Treatment of Non-Small Cell Lung Cancer; Applicant Allos Therapeutics, Inc.; Status Patented Case.
- 2013-03-13: Application 13800593; Invention Optically Pure Diastereomers of 10-Propargyl-10-Deazaaminopterin and Methods of Using Same for the treatment of cancer; Applicant ALLOS THERAPEUTICS, INC.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-08-25 | 14467812 | (2S)-2-[[4-[(1R)-1-[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]BUT-3-YNYL]BENZOYL]AMINO]PENTANEDIOIC ACID FOR THE TREATMENT OF INFLAMMATORY DISORDERS | Allos Therapeutics, Inc. | Patented Case | 2015-11-17 | 9187481 | US20140364437A1 | Gijsbertus J. Pronk | United States | WILLIS, DOUGLAS M |
| 2013-07-17 | 13944596 | Combination of 10-Propargyl-10-Deazaaminopterin and Erlotinib for the Treatment of Non-Small Cell Lung Cancer | Allos Therapeutics, Inc. | Patented Case | 2018-02-27 | 9901578 | US20130303536A1 | Gijsbertus J. Pronk | United States | MCMILLIAN, KARA RENITA |
| 2013-03-13 | 13800593 | Optically Pure Diastereomers of 10-Propargyl-10-Deazaaminopterin and Methods of Using Same for the treatment of cancer | ALLOS THERAPEUTICS, INC. | Patented Case | 2014-09-16 | 8835433 | US20130197004A1 | Gijsbertus J. Pronk | United States | WILLIS, DOUGLAS M |